Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Kiromic BioPharma, Inc. (KRBP : NSDQ)
 
 • Company Description   
Kiromic BioPharma Inc. is a discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma Inc. is based in HOUSTON.

Number of Employees: 59

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.33 Daily Weekly Monthly
20 Day Moving Average: 319,932 shares
Shares Outstanding: 15.59 (millions)
Market Capitalization: $5.17 (millions)
Beta: 0.61
52 Week High: $11.00
52 Week Low: $0.29
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -52.57% -46.58%
12 Week -45.00% -39.53%
Year To Date -78.30% -73.49%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7707 FANNIN ST. SUITE 140
-
HOUSTON,TX 77054
USA
ph: 832-968-4888
fax: -
bus.dev@kiromic.com http://www.kiromic.com
 
 • General Corporate Information   
Officers
Pietro Bersani - Chief Executive Officer
Daniel Clark - Chief Financial Officer
Americo Cicchetti - Director
Michael Nagel - Director
Karen Reeves - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 497634105
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/12/22
Share - Related Items
Shares Outstanding: 15.59
Most Recent Split Date: (:1)
Beta: 0.61
Market Capitalization: $5.17 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.45 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.26
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 9.43%
vs. Previous Quarter: -160.76%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -32.99
12/31/21 - -19.90
09/30/21 - -119.10
ROA
03/31/22 - -29.02
12/31/21 - -18.03
09/30/21 - -108.33
Current Ratio
03/31/22 - 4.08
12/31/21 - 7.94
09/30/21 - 24.86
Quick Ratio
03/31/22 - -
12/31/21 - 7.94
09/30/21 - 24.86
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 1.29
12/31/21 - 1.77
09/30/21 - 2.43
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©